$460 Million is the total value of SECTOR GAMMA AS's 40 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 12.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $24,360,000 | +12.1% | 333,558 | -4.3% | 5.29% | +3.6% |
| CAH | Sell | CARDINAL HEALTH INC | $21,391,000 | -16.4% | 377,270 | -24.0% | 4.65% | -22.7% |
| CVS | Sell | CVS HEALTH CORP | $20,128,000 | -5.4% | 198,873 | -3.5% | 4.37% | -12.5% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $17,509,000 | -17.5% | 395,335 | -20.9% | 3.80% | -23.7% |
| ANTM | Sell | ANTHEM INC | $14,254,000 | -10.6% | 29,018 | -15.7% | 3.10% | -17.4% |
| OGN | Sell | ORGANON & CO | $11,867,000 | -9.7% | 339,738 | -21.3% | 2.58% | -16.5% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $6,980,000 | +9.5% | 188,439 | -10.1% | 1.52% | +1.2% |
| BDX | Sell | BECTON DICKINSON & CO | $6,978,000 | -63.3% | 26,233 | -65.3% | 1.52% | -66.1% |
| PFE | Sell | PFIZER INC | $6,717,000 | -60.1% | 129,738 | -54.5% | 1.46% | -63.1% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $6,461,000 | -24.7% | 24,758 | -36.6% | 1.40% | -30.4% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $6,149,000 | -38.7% | 79,759 | -29.8% | 1.34% | -43.3% |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $4,385,000 | +12.6% | 1,466,678 | -0.2% | 0.95% | +4.2% |
| XRAY | Sell | DENTSPLY SIRONA INC | $2,732,000 | -57.4% | 55,516 | -51.6% | 0.59% | -60.6% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $976,000 | -74.5% | 11,875 | -54.5% | 0.21% | -76.4% |
| BNTX | Exit | BIONTECH SEsponsored ads | $0 | – | -13,032 | -100.0% | -0.79% | – |
| LH | Exit | LABORATORY CORP AMER HLDGS | $0 | – | -23,377 | -100.0% | -1.73% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-06
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.